LPL Financial
OLMA icon

LPL Financial’s Olema Pharmaceuticals OLMA Stock Holding History

LPL Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$737K Buy
58,941
+1,536
+3% +$20.6K ﹤0.01% 4681
2026
Q1 		$856K Buy
57,405
+1,210
+2% +$26.9K ﹤0.01% 4314
2025
Q4 		$1.4M Sell
56,195
-40,480
-42% -$720K ﹤0.01% 3731
2025
Q3 		$946K Buy
96,675
+30,030
+45% +$180K ﹤0.01% 4048
2025
Q2 		$284K Buy
66,645
+10,686
+19% +$47.6K ﹤0.01% 4811
2025
Q1 		$210K Buy
+55,959
New +$281K ﹤0.01% 4838

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

LPL Financial's OLMA Position: Q2 2026 in Review

LPL Financial increased its Olema Pharmaceuticals (OLMA) stake by 2.7% in Q2 2026, buying an estimated $20.6K and bringing the position to 58,941 shares worth $737K. The position accounts for ﹤0.01% of the portfolio, ranked #4681.

LPL Financial first reported a position in OLMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.4M in Q4 2025. 45 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • LPL Financial held 58,941 shares of Olema Pharmaceuticals worth $737K as of Q2 2026.
  • LPL Financial bought 1,536 Olema Pharmaceuticals shares in Q2 2026, an estimated $20.6K.
  • Olema Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4681 holding.
  • LPL Financial first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • LPL Financial's Olema Pharmaceuticals position peaked at $1.4M in Q4 2025.
  • 45 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.